OLP Therapeutics, an Oakland, California startup, has released its first product line: natural, unaltered psilocybin mushroom medicines with exact, standardized quantities of active ingredients.
Read More
Breakthrough Therapy Designation establishes FDA’s organizational commitment to promoting an efficient development program for psilocybin in MDD.
Read More